- Erratum
- Open access
- Published:
Erratum to: potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis
Journal of Nanobiotechnology volume 11, Article number: 23 (2013)
Correction
After the publication of this work [1], it was brought to our attention that there might have been an error during compilation of the gel bands in Figure 1. We regret such unintentional errors and any inconvenience this may have caused. In order to ensure that the published figure is correct, we have repeated the experiments to provide a corrected version of Figure 1.
Immunoblot analysis of CLL B cells exposed to gold particles (Au) alone, AbVF alone at 5 and 25 μg/ml and AU-AbVF at 5 and 25 μg/ml. Note the prominent PARP cleavage, decrease in caspase 3, Mcl-1 and moderate change in Bcl-2 for CLL B cells treated with Au-AbVF at 25 μg/ml. These changes were noted but less evident for Au-AbVF at the 5 μg/ml dose.
References
Nancy B, Lee YK, Chitta Ranjan P, Shanfeng W, Lu L, Secreto C, Banerjee PC, Yaszemski MJ, Kay NE, Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. Priyabrata Mukherjee, Resham Bhattacharya: Debabrata Mukhopadhyay. J Nanobiotechnol. 2007, 5: 4-10.1186/1477-3155-5-4.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at 10.1186/1477-3155-5-4
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Mukherjee, P., Bhattacharya, R., Bone, N. et al. Erratum to: potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. J Nanobiotechnol 11, 23 (2013). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/1477-3155-11-23
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/1477-3155-11-23